Tag: entrepreneurs
-
Fertility Device Company Gains $9.7M in Early Funds
A two year-old medical device enterprise making a fertility tracker for women is raising $9.7 million in its first venture finance round.
-
Small-Business Grants Awarded for Neurological Diseases
A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Phone-Based Microscope Developed for Water Testing
An engineering lab at University of Houston in Texas designed an inexpensive lens that when placed over a smartphone’s camera, turns the phone into a microscope.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Spinach Enhanced to Detect Chemicals, Send Signals
A chemical engineering group showed the feasibility of embedding sensors in common spinach plants that can detect and signal the presence of explosive chemicals in the soil.
-
Institutes, Companies Form Business to Bridge Discovery Gap
Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials.
-
Google Acquires Visual Interaction Tech Company
Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes.
-
3-D Printing Creates Heart-on-Chip with Sensors
Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing.
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.